{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:50:38Z","timestamp":1791319838380,"version":"4.3.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jneuroim.2026.579015","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T15:42:49Z","timestamp":1782574969000},"page":"579015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical features, imaging findings, and treatment outcomes of optic neuritis associated with anti-CRMP5 antibodies: a systematic review"],"prefix":"10.1016","volume":"419","author":[{"given":"Rafael Martins","family":"Themoteo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang Han","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana Laura Aihara","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateus Mistieri","family":"Simabukuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Castello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Vitor","family":"Mahler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Matiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Diogo","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jneuroim.2026.579015_bb0005","doi-asserted-by":"crossref","first-page":"302","DOI":"10.31348\/2021\/36","article-title":"Paraneoplastic optic neuropathy as an initial clinical manifestation of small cell lung cancer. A case report","volume":"77","author":"Akbulut","year":"2021","journal-title":"Cesk. Slov. Oftalmol."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.579015_bb0010","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00415-006-0471-x","article-title":"Isolated paraneoplastic optic neuropathy associated with small-cell lung cancer and anti-CV2 antibodies","volume":"254","author":"Ar\u00e9s-Luque","year":"2007","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579015_bb0015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000443522","article-title":"Paraneoplastic choreoathetosis in a patient with small cell lung carcinoma and anti-crmp5\/cv2: a case report","volume":"8","author":"Aydin","year":"2016","journal-title":"Case Rep. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579015_bb0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/WCO.0000000000001128","article-title":"Optic neuritis: current challenges in diagnosis and management","volume":"36","author":"Benard-Seguin","year":"2022","journal-title":"Curr. Opin. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579015_bib267","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1474-4422(22)00187-9","article-title":"Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment","volume":"22","author":"Bennet","year":"2023","journal-title":"Lancet Neurol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2026.579015_bb0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jneuroim.2006.01.018","article-title":"Expression of the onconeural CV2\/CRMP5 antigen in thymus and thymoma","volume":"174","author":"Camdessanch\u00e9","year":"2006","journal-title":"J. Neuroimmunol."},{"issue":"11","key":"10.1016\/j.jneuroim.2026.579015_bb0040","article-title":"Non-progressive CRMP-5-associated perifoveal retinopathy in a breast cancer patient: a rare paraneoplastic phenomenon","volume":"16","author":"Canut","year":"2024","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.jneuroim.2026.579015_bb0050","doi-asserted-by":"crossref","first-page":"403","DOI":"10.17712\/nsj.2020.5.20200095","article-title":"Small cell carcinoma presenting as ocular paraneoplastic syndrome due to CRMP-5","volume":"25","author":"Castle","year":"2020","journal-title":"Neurosciences"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579015_bb0060","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1097\/WNO.0000000000001613","article-title":"Paraneoplastic optic neuropathy in a patient with glioblastoma","volume":"44","author":"Choi","year":"2022","journal-title":"J. Neuroophthalmol."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579015_bb0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ophtha.2019.09.012","article-title":"Collapsin response-mediator protein 5\u2013associated retinitis, vitritis, and optic disc edema","volume":"127","author":"Cohen","year":"2020","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.jneuroim.2026.579015_bb0070","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.ajo.2003.09.031","article-title":"Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG","volume":"136","author":"Cross","year":"2003","journal-title":"Am. J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.jneuroim.2026.579015_bb0075","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579015_bb0080","doi-asserted-by":"crossref","DOI":"10.1001\/archneur.55.3.405","article-title":"Paraneoplastic cerebellar syndrome and optic neuritis with anti-CV2 antibodies","volume":"55","author":"de la Sayette","year":"1998","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579015_bb0085","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/jnnp.2006.097972","article-title":"Devic\u2019s syndrome-like phenotype associated with thymoma and anti-CV2\/CRMP5 antibodies","volume":"78","author":"Ducray","year":"2006","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579015_bb0090","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurology Neuroimmunology & Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2026.579015_bb0100","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajo.2020.07.014","article-title":"Population-based incidence of optic neuritis in the era of aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies","volume":"220","author":"Hassan","year":"2020","journal-title":"Am. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.jneuroim.2026.579015_bib268","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ana.1270","article-title":"Are the \u201cnewly discovered\u201d paraneoplastic anti-collapsin response-mediator protein 5 antibodies simply anti-CD2 antibodies?","volume":"50","author":"Honnorat","year":"2001","journal-title":"Ann Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579015_bb0110","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/jnnp.2007.138016","article-title":"Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2\/CRMP5 antibodies","volume":"80","author":"Honnorat","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579015_bb0115","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/01658107.2016.1241283","article-title":"Anti-collapsing response-mediating protein-5 antibody\u2013positive paraneoplastic perioptic neuritis without typical neurological symptoms","volume":"41","author":"Igarashi","year":"2016","journal-title":"Neuro-Ophthalmol."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579015_bb0120","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.clineuro.2011.10.048","article-title":"Antibodies to CV2\/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature","volume":"114","author":"Jarius","year":"2012","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579015_bb0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/WNO.0b013e3181675479","article-title":"High-titer collapsin response-mediating protein-associated (CRMP-5) paraneoplastic optic neuropathy and vitritis as the only clinical manifestations in a patient with small cell lung carcinoma","volume":"28","author":"Margolin","year":"2008","journal-title":"J. Neuro-Ophthalmol."},{"key":"10.1016\/j.jneuroim.2026.579015_bb0135","series-title":"JBI Manual for Evidence Synthesis","article-title":"Chapter 7: Systematic reviews of etiology and risk","author":"Moola","year":"2020"},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579015_bb0145","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.survophthal.2009.03.008","article-title":"Glazed (vision) and confused","volume":"55","author":"Moss","year":"2010","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jneuroim.2026.579015_bb0150","doi-asserted-by":"crossref","DOI":"10.11124\/JBISRIR-D-19-00099","article-title":"Methodological quality of case series studies","author":"Munn","year":"2019","journal-title":"JBI Database Syst. Rev. Implement. Rep."},{"issue":"6","key":"10.1016\/j.jneuroim.2026.579015_bb0155","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/sj.eye.6702730","article-title":"CRMP-5-IgG in patient with paraneoplastic optic neuritis with lung adenocarcinoma","volume":"21","author":"Murakami","year":"2007","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579015_bib266","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41590-017-0006-x","article-title":"The twilight of immunity: emerging concepts in aging of the immune system","volume":"19","author":"Nikolich-\u017dugich","year":"2017","journal-title":"Nat. Immunol."},{"issue":"100170","key":"10.1016\/j.jneuroim.2026.579015_bb0165","article-title":"Anti-CRMP5 optic neuropathy associated with oral squamous cell carcinoma","volume":"3","author":"Nulton","year":"2023","journal-title":"Neuroimmunol. Rep."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579015_bb0170","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579015_bb0175","doi-asserted-by":"crossref","first-page":"750A","DOI":"10.1016\/j.chest.2016.08.845","article-title":"CRMP5-positive paraneoplastic encephalitis in a patient with occult small cell lung cancer","volume":"150","author":"Parsamehr","year":"2016","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.jneuroim.2026.579015_bb0180","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S1474-4422(22)00200-9","article-title":"Diagnosis and classification of optic neuritis","volume":"21","author":"Petzold","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2026.579015_bb0185","author":"Posit team"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579015_bb0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000543516","article-title":"Bilateral paraneoplastic optic neuropathy as the first presentation of preclinical small cell lung cancer: case report","volume":"16","author":"Sharif","year":"2025","journal-title":"Case Rep. Ophthalmol."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579015_bb0210","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/01.wno.0000235578.80051.0e","article-title":"Small cell lung carcinoma presenting as Collapsin Response-Mediating Protein (CRMP)-5 paraneoplastic optic neuropathy","volume":"26","author":"Sheorajpanday","year":"2006","journal-title":"J. Neuroophthalmol."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579015_bb0215","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/WNO.0000000000000619","article-title":"Paraneoplastic optic neuropathy and pineal germinoma with collapsin response-mediating protein antibodies","volume":"38","author":"Shukla","year":"2018","journal-title":"J. Neuroophthalmol."},{"issue":"14_supplement","key":"10.1016\/j.jneuroim.2026.579015_bb0220","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.84.14_supplement.P4.236","article-title":"CRMP-5 antibody in paraneoplastic optic neuritis and sensory motor neuropathy associated with small cell lung cancer (P4.236)","volume":"84","author":"Sumida","year":"2015","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jneuroim.2026.579015_bb0230","doi-asserted-by":"crossref","DOI":"10.4321\/S0365-66912007001200013","article-title":"Neuritis \u00f3ptica paraneopl\u00e1sica en carcinoma microc\u00edtico pulmonar desconocido definida por marcador CRMP-5-IgG","volume":"82","author":"Toribio-Garc\u00eda","year":"2007","journal-title":"Arch. Soc. Esp. Oftalmol."},{"issue":"01","key":"10.1016\/j.jneuroim.2026.579015_bb0235","doi-asserted-by":"crossref","first-page":"036","DOI":"10.1055\/s-0043-1777353","article-title":"Updates in the management of paraneoplastic syndrome","volume":"44","author":"Verma","year":"2024","journal-title":"Semin. Neurol."},{"issue":"11","key":"10.1016\/j.jneuroim.2026.579015_bb0245","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.4103\/1673-5374.371400","article-title":"An overview on CV2\/CRMP5 antibody-associated paraneoplastic neurological syndromes","volume":"18","author":"Wang","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jneuroim.2026.579015_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1163615","article-title":"Collapsin response mediator protein 5-associated optic neuropathy: clinical characteristics, radiologic clues, and outcomes","volume":"14","author":"Yan","year":"2023","journal-title":"Front. Neurol."},{"issue":"5","key":"10.1016\/j.jneuroim.2026.579015_bb0260","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-242082","article-title":"Paraneoplastic optic neuropathy secondary to adenocarcinoma of the lung","volume":"14","author":"Yap","year":"2021","journal-title":"BMJ Case Rep."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579015_bb0265","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E","article-title":"CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity","volume":"49","author":"Yu","year":"2001","journal-title":"Ann. Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826001645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826001645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:58:29Z","timestamp":1791316709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572826001645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":41,"alternative-id":["S0165572826001645"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579015","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features, imaging findings, and treatment outcomes of optic neuritis associated with anti-CRMP5 antibodies: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"579015"}}